Free tool
Oncology stocks
We cover 8 companies grouped under the Oncology theme. The median market value in the group is $27.47B. Across the group, the median move over the past trading day is +1.27%. Price change over the past year runs from −8.8% to +184.9% across the middle 80 percent of the group, with a median of +45.3%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
8 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | $67.92 | +8.57% | +28.36% | +49.31% |
| RVMD | Revolution Medicines, Inc. | $211.38 | +12.39% | +167.50% | +492.60% |
| ONC | BeOne Medicines AG | $376.37 | +15.49% | +21.01% | +21.95% |
| BNTX | BioNTech SE | $114.05 | +25.21% | +17.95% | +8.55% |
| INCY | Incyte Corporation | $129.72 | +9.13% | +27.90% | +53.04% |
| GMAB | Genmab A/S | $34.36 | +19.31% | +7.98% | +41.34% |
| EXEL | Exelixis, Inc. | $56.72 | +1.63% | +30.15% | +49.66% |
| SMMT | Summit Therapeutics Inc. | $13.36 | +1.95% | −23.74% | −49.14% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.